Page last updated: 2024-10-29
ioxilan and Adnexal Diseases
ioxilan has been researched along with Adnexal Diseases in 1 studies
Adnexal Diseases: Diseases of the uterine appendages (ADNEXA UTERI) including diseases involving the OVARY, the FALLOPIAN TUBES, and ligaments of the uterus (BROAD LIGAMENT; ROUND LIGAMENT).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Iothalamate meglumine 60% was associated with mild inflammatory infiltrate, mucosal edema, giant cell reaction, and periovarian adhesions that were bilateral but more pronounced on the injected side." | 1.28 | Effects of contrast agents on the fallopian tube in a rabbit model. ( Eisenberg, AD; Holburn, GE; Moore, DE; Page, DL; Segars, JH; Winfield, AC, 1990) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Moore, DE | 1 |
| Segars, JH | 1 |
| Winfield, AC | 1 |
| Page, DL | 1 |
| Eisenberg, AD | 1 |
| Holburn, GE | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Can Contrast Infused Sonography Using Air Bubbles Replace Hysterosalpingogram as the Diagnostic Evaluation of Fallopian Tube Patency Following Hysteroscopic Sterilization Using Essure[NCT02628873] | | 21 participants (Actual) | Interventional | 2015-12-31 | Terminated (stopped due to Essure no longer sold in the US after Dec 2018; Sponsor requested trial be ended) |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Physician Evaluation of Uterine Cavity
"Observed image of uterus (normal or not normal). Assessor commented on uterine cavity to determine whether cavity was normal versus abnormal, e.g., bicornuate uterus or any notable uterine deformity. Data were coded as normal' or not normal." (NCT02628873)
Timeframe: At time of HyCoSy procedure
| Intervention | Participants (Count of Participants) |
|---|
| Arm 1 (HyCoSy Followed by HSG) | 13 |
| Arm 2 (HSG Followed by HyCoSy) | 6 |
Fallopian Tube Patency - HyCoSy vs HSG
Observed flow of fluid/bubbles through fallopian tubes. (NCT02628873)
Timeframe: At time of procedure
| Intervention | fallopian tubes observed to be closed (Count of Units) |
|---|
| Number of tubes closed per first procedure | Number of tubes closed per second procedure |
|---|
| Arm 1 (HyCoSy Followed by HSG) | 24 | 25 |
,| Arm 2 (HSG Followed by HyCoSy) | 12 | 12 |
Pain Scores
Patient reported pain scale score on visual pain scale (rated 0 for no pain to 10 for severe pain with corresponding faces) (NCT02628873)
Timeframe: At time of procedures
| Intervention | units on a scale (Mean) |
|---|
| HSG post procedure pain score | HyCoSy post procedure pain score |
|---|
| Arm 1 (HyCoSy Followed by HSG) | 1.4 | 2.4 |
,| Arm 2 (HSG Followed by HyCoSy) | 1.8 | 2.3 |
Other Studies
1 other study available for ioxilan and Adnexal Diseases